Abciximab
The therapeutic efficacy of Abciximab can be decreased when used in combination with Etonogestrel.
Acarbose
The therapeutic efficacy of Acarbose can be decreased when used in combination with Etonogestrel.
Acenocoumarol
Etonogestrel may decrease the anticoagulant activities of Acenocoumarol.
Advertisement
Acetohexamide
The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Etonogestrel.
Acetyl Sulfisoxazole
The metabolism of Etonogestrel can be decreased when combined with Acetyl sulfisoxazole.
Acitretin
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Acitretin.
Advertisement
Adapalene
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Adapalene.
Alitretinoin
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Alitretinoin.
Alogliptin
The therapeutic efficacy of Alogliptin can be decreased when used in combination with Etonogestrel.
Advertisement
Amiodarone
The metabolism of Etonogestrel can be decreased when combined with Amiodarone.
Amobarbital
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Amobarbital.
Ancrod
The therapeutic efficacy of Ancrod can be decreased when used in combination with Etonogestrel.
Antithrombin III
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Etonogestrel.
Antithrombin III, Human
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Etonogestrel.
Apalutamide
The serum concentration of Etonogestrel can be decreased when it is combined with Apalutamide.
Apixaban
The therapeutic efficacy of Apixaban can be decreased when used in combination with Etonogestrel.
Aprepitant
The serum concentration of Etonogestrel can be decreased when it is combined with Aprepitant.
Ardeparin
The therapeutic efficacy of Ardeparin can be decreased when used in combination with Etonogestrel.
Argatroban
The therapeutic efficacy of Argatroban can be decreased when used in combination with Etonogestrel.
Argatroban Anhydrous
The therapeutic efficacy of Argatroban can be decreased when used in combination with Etonogestrel.
Artemether
The serum concentration of Etonogestrel can be decreased when it is combined with Artemether.
Asunaprevir
The serum concentration of Etonogestrel can be decreased when it is combined with Asunaprevir.
Atazanavir
The serum concentration of Etonogestrel can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Etonogestrel can be decreased when combined with Atomoxetine.
Barbexaclone
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Barbexaclone.
Barbital
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Barbital.
Becaplermin
The therapeutic efficacy of Becaplermin can be decreased when used in combination with Etonogestrel.
Bexarotene
The serum concentration of Etonogestrel can be decreased when it is combined with Bexarotene.
Bivalirudin
The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Etonogestrel.
Boceprevir
The serum concentration of Etonogestrel can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Etonogestrel can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Etonogestrel can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Etonogestrel can be decreased when it is combined with Bosentan.
C1 esterase inhibitor (human)
Etonogestrel may increase the thrombogenic activities of Human C1-esterase inhibitor.
C1 esterase inhibitor (recombinant)
Etonogestrel may increase the thrombogenic activities of Conestat alfa.
Canagliflozin
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Etonogestrel.
Canagliflozin Anhydrous
The therapeutic efficacy of Canagliflozin can be decreased when used in combination with Etonogestrel.
Carbamazepine
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Carbamazepine.
Ceritinib
The serum concentration of Etonogestrel can be increased when it is combined with Ceritinib.
Certoparin
The therapeutic efficacy of Certoparin can be decreased when used in combination with Etonogestrel.
Chlorpropamide
The therapeutic efficacy of Chlorpropamide can be decreased when used in combination with Etonogestrel.
Cholestyramine Resin
The serum concentration of Etonogestrel can be decreased when it is combined with Cholestyramine.
Citric Acid
The therapeutic efficacy of Citric Acid can be decreased when used in combination with Etonogestrel.
Citric Acid, Anhydrous
The therapeutic efficacy of Citric Acid can be decreased when used in combination with Etonogestrel.
Clarithromycin
The metabolism of Etonogestrel can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Etonogestrel can be decreased when combined with Clemastine.
Clobazam
The serum concentration of Etonogestrel can be decreased when it is combined with Clobazam.
Clotrimazole
The metabolism of Etonogestrel can be decreased when combined with Clotrimazole.
Cobicistat
The serum concentration of Etonogestrel can be increased when it is combined with Cobicistat.
Colesevelam
The serum concentration of Etonogestrel can be decreased when it is combined with Colesevelam.
Colestipol
The serum concentration of Etonogestrel can be decreased when it is combined with Colestipol.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Etonogestrel.
Crizotinib
The metabolism of Etonogestrel can be decreased when combined with Crizotinib.
Curcumin
The metabolism of Etonogestrel can be decreased when combined with Curcumin.
Cyclosporine
The metabolism of Etonogestrel can be decreased when combined with Cyclosporine.
Dabigatran Etexilate
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Etonogestrel.
Dabrafenib
The serum concentration of Etonogestrel can be decreased when it is combined with Dabrafenib.
Dalteparin
The therapeutic efficacy of Dalteparin can be decreased when used in combination with Etonogestrel.
Danaparoid
The therapeutic efficacy of Danaparoid can be decreased when used in combination with Etonogestrel.
Darunavir
The serum concentration of Etonogestrel can be decreased when it is combined with Darunavir.
Dasatinib
The serum concentration of Etonogestrel can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Etonogestrel can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Etonogestrel can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Etonogestrel can be decreased when combined with Delavirdine.
Desirudin
The therapeutic efficacy of Desirudin can be decreased when used in combination with Etonogestrel.
Dextran
The therapeutic efficacy of Dextran can be decreased when used in combination with Etonogestrel.
Dextran 40
The therapeutic efficacy of Dextran 40 can be decreased when used in combination with Etonogestrel.
Dextran 70
The therapeutic efficacy of Dextran 70 can be decreased when used in combination with Etonogestrel.
Dextran 75
The therapeutic efficacy of Dextran 75 can be decreased when used in combination with Etonogestrel.
Dicumarol
Etonogestrel may decrease the anticoagulant activities of Dicoumarol.
Dihydroergotamine
The metabolism of Etonogestrel can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Etonogestrel can be decreased when combined with Diltiazem.
Doxycycline
The metabolism of Etonogestrel can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Etonogestrel can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Etonogestrel can be decreased when combined with Dronedarone.
Dulaglutide
The therapeutic efficacy of Dulaglutide can be decreased when used in combination with Etonogestrel.
Edetic Acid
The therapeutic efficacy of Edetic Acid can be decreased when used in combination with Etonogestrel.
Edoxaban
The therapeutic efficacy of Edoxaban can be decreased when used in combination with Etonogestrel.
Efavirenz
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Efavirenz.
Empagliflozin
The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Etonogestrel.
Enoxaparin
The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Etonogestrel.
Enoxaparin sodium
The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Etonogestrel.
Enzalutamide
The serum concentration of Etonogestrel can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Etonogestrel can be decreased when combined with Erythromycin.
Eslicarbazepine Acetate
The serum concentration of Etonogestrel can be decreased when it is combined with Eslicarbazepine acetate.
Ethylenediaminetetraacetate
The therapeutic efficacy of Edetic Acid can be decreased when used in combination with Etonogestrel.
Exenatide
The therapeutic efficacy of Exenatide can be decreased when used in combination with Etonogestrel.
Felbamate
The serum concentration of Etonogestrel can be decreased when it is combined with Felbamate.
Ferulic Acid
The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Etonogestrel.
Flibanserin
The serum concentration of Flibanserin can be increased when it is combined with Etonogestrel.
Fluconazole
The metabolism of Etonogestrel can be decreased when combined with Fluconazole.
Fluindione
Etonogestrel may decrease the anticoagulant activities of Fluindione.
Fluvoxamine
The metabolism of Etonogestrel can be decreased when combined with Fluvoxamine.
Fondaparinux
The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Etonogestrel.
Fondaparinux sodium
The therapeutic efficacy of Fondaparinux sodium can be decreased when used in combination with Etonogestrel.
Fosamprenavir
The serum concentration of the active metabolites of Fosamprenavir can be reduced when Fosamprenavir is used in combination with Etonogestrel resulting in a loss in efficacy.
Fosaprepitant
The serum concentration of Etonogestrel can be decreased when it is combined with Fosaprepitant.
Fosphenytoin
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Fosphenytoin.
Fusidate
The serum concentration of Etonogestrel can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Etonogestrel can be increased when it is combined with Fusidic Acid.
Glibornuride
The therapeutic efficacy of Glibornuride can be decreased when used in combination with Etonogestrel.
Gliclazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Etonogestrel.
Glimepiride
The therapeutic efficacy of Glimepiride can be decreased when used in combination with Etonogestrel.
Glipizide
The therapeutic efficacy of Glipizide can be decreased when used in combination with Etonogestrel.
Gliquidone
The therapeutic efficacy of Gliquidone can be decreased when used in combination with Etonogestrel.
Glyburide
The therapeutic efficacy of Glyburide can be decreased when used in combination with Etonogestrel.
Griseofulvin
The serum concentration of Etonogestrel can be decreased when it is combined with Griseofulvin.
Griseofulvin microsize
The serum concentration of Etonogestrel can be decreased when it is combined with Griseofulvin.
Heparin
The therapeutic efficacy of Heparin can be decreased when used in combination with Etonogestrel.
Hexobarbital
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Hexobarbital.
Hypoxis hemerocallidea root extract
The serum concentration of Etonogestrel can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Etonogestrel can be decreased when combined with Idelalisib.
Imatinib
The metabolism of Etonogestrel can be decreased when combined with Imatinib.
Indinavir
The metabolism of Etonogestrel can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Etonogestrel can be decreased when combined with Indinavir.
Insulin Detemir
The therapeutic efficacy of Insulin Detemir can be decreased when used in combination with Etonogestrel.
Insulin Glargine
The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Etonogestrel.
insulin human, rDNA origin
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Etonogestrel.
Insulin Lispro
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Etonogestrel.
Insulin, Aspart Protamine, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Etonogestrel.
Insulin, Aspart, Human
The therapeutic efficacy of Insulin Aspart can be decreased when used in combination with Etonogestrel.
Insulin, Glulisine, Human
The therapeutic efficacy of Insulin Glulisine can be decreased when used in combination with Etonogestrel.
Insulin, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Etonogestrel.
Insulin, Protamine Lispro, Human
The therapeutic efficacy of Insulin Lispro can be decreased when used in combination with Etonogestrel.
Insulin, Regular, Pork
The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Etonogestrel.
Isavuconazole
The serum concentration of Etonogestrel can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Etonogestrel can be decreased when combined with Isavuconazonium.
Isotretinoin
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Isotretinoin.
Isradipine
The metabolism of Etonogestrel can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Etonogestrel can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Etonogestrel can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Etonogestrel can be decreased when combined with Ketoconazole.
Lamotrigine
Etonogestrel may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy.
Lepirudin
The therapeutic efficacy of Lepirudin can be decreased when used in combination with Etonogestrel.
Linagliptin
The therapeutic efficacy of Linagliptin can be decreased when used in combination with Etonogestrel.
Liraglutide
The therapeutic efficacy of Liraglutide can be decreased when used in combination with Etonogestrel.
Lopinavir
The serum concentration of Etonogestrel can be decreased when it is combined with Lopinavir.
Lovastatin
The metabolism of Etonogestrel can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Etonogestrel can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Etonogestrel can be decreased when it is combined with Lumacaftor.
Mephobarbital
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Methylphenobarbital.
Metformin
The therapeutic efficacy of Metformin can be decreased when used in combination with Etonogestrel.
Methohexital
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Methohexital.
Metreleptin
The serum concentration of Etonogestrel can be decreased when it is combined with Metreleptin.
Mifepristone
The serum concentration of Etonogestrel can be increased when it is combined with Mifepristone.
Miglitol
The therapeutic efficacy of Miglitol can be decreased when used in combination with Etonogestrel.
Miglustat
The therapeutic efficacy of Miglustat can be decreased when used in combination with Etonogestrel.
Mitotane
The serum concentration of Etonogestrel can be decreased when it is combined with Mitotane.
MYCOPHENOLATE
The serum concentration of Etonogestrel can be decreased when it is combined with Mycophenolic acid.
Mycophenolic Acid
The serum concentration of Etonogestrel can be decreased when it is combined with Mycophenolic acid.
Nadroparin
The therapeutic efficacy of Nadroparin can be decreased when used in combination with Etonogestrel.
Nateglinide
The therapeutic efficacy of Nateglinide can be decreased when used in combination with Etonogestrel.
Nefazodone
The metabolism of Etonogestrel can be decreased when combined with Nefazodone.
Nelfinavir
The serum concentration of Etonogestrel can be decreased when it is combined with Nelfinavir.
Netupitant
The serum concentration of Etonogestrel can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Etonogestrel can be decreased when it is combined with Nevirapine.
Nilotinib
The metabolism of Etonogestrel can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Etonogestrel can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Etonogestrel can be increased when it is combined with Osimertinib.
Oxcarbazepine
The serum concentration of Etonogestrel can be decreased when it is combined with Oxcarbazepine.
Palbociclib
The serum concentration of Etonogestrel can be increased when it is combined with Palbociclib.
Pentaerythritol Tetranitrate
The therapeutic efficacy of Pentaerythritol Tetranitrate can be decreased when used in combination with Etonogestrel.
Pentobarbital
The metabolism of Etonogestrel can be increased when combined with Pentobarbital.
Pentosan Polysulfate
The therapeutic efficacy of Pentosan Polysulfate can be decreased when used in combination with Etonogestrel.
Perampanel
The serum concentration of Etonogestrel can be decreased when it is combined with Perampanel.
Phenformin
The therapeutic efficacy of Phenformin can be decreased when used in combination with Etonogestrel.
Phenindione
Etonogestrel may decrease the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Etonogestrel can be increased when combined with Phenobarbital.
Phenprocoumon
Etonogestrel may decrease the anticoagulant activities of Phenprocoumon.
Phenytoin
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Phenytoin.
Pioglitazone
The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Etonogestrel.
Posaconazole
The metabolism of Etonogestrel can be decreased when combined with Posaconazole.
Potassium Citrate
The therapeutic efficacy of Potassium Citrate can be decreased when used in combination with Etonogestrel.
Pramlintide
The therapeutic efficacy of Pramlintide can be decreased when used in combination with Etonogestrel.
Primidone
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Primidone.
protein C, human
The therapeutic efficacy of Protein C can be decreased when used in combination with Etonogestrel.
protein S, human
The therapeutic efficacy of Protein S human can be decreased when used in combination with Etonogestrel.
Protocatechualdehyde
The therapeutic efficacy of Protocatechualdehyde can be decreased when used in combination with Etonogestrel.
Ranolazine
The metabolism of Etonogestrel can be decreased when combined with Ranolazine.
Regular Insulin, Human
The therapeutic efficacy of Insulin Human can be decreased when used in combination with Etonogestrel.
Repaglinide
The therapeutic efficacy of Repaglinide can be decreased when used in combination with Etonogestrel.
Reviparin
The therapeutic efficacy of Reviparin can be decreased when used in combination with Etonogestrel.
Reviparin sodium
The therapeutic efficacy of Reviparin can be decreased when used in combination with Etonogestrel.
Rifabutin
The metabolism of Etonogestrel can be increased when combined with Rifabutin.
Rifampin
The metabolism of Etonogestrel can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Etonogestrel can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Etonogestrel can be decreased when it is combined with Rifaximin.
Rivaroxaban
The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Etonogestrel.
Rosiglitazone
The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Etonogestrel.
Rucaparib
The metabolism of Etonogestrel can be decreased when combined with Rucaparib.
Saquinavir
The serum concentration of Etonogestrel can be decreased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Etonogestrel can be decreased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Sarilumab.
Saxagliptin
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Etonogestrel.
Saxagliptin Anhydrous
The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Etonogestrel.
Secobarbital
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Secobarbital.
Selegiline
The serum concentration of Selegiline can be increased when it is combined with Etonogestrel.
Sildenafil
The metabolism of Etonogestrel can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Etonogestrel can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Etonogestrel can be increased when it is combined with Simeprevir.
Sitagliptin
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Etonogestrel.
Sitagliptin Phosphate
The therapeutic efficacy of Sitagliptin can be decreased when used in combination with Etonogestrel.
Sodium Citrate
The therapeutic efficacy of Sodium Citrate can be decreased when used in combination with Etonogestrel.
ST. JOHN'S WORT EXTRACT
The serum concentration of Etonogestrel can be decreased when it is combined with St. John's Wort.
Sugammadex
The serum concentration of Etonogestrel can be decreased when it is combined with Sugammadex.
Sulfisoxazole
The metabolism of Etonogestrel can be decreased when combined with Sulfisoxazole.
Telaprevir
The serum concentration of Etonogestrel can be decreased when it is combined with Telaprevir.
Telithromycin
The metabolism of Etonogestrel can be decreased when combined with Telithromycin.
Thalidomide
Etonogestrel may increase the thrombogenic activities of Thalidomide.
Thiamylal
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Thiamylal.
Thiopental
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Thiopental.
Thiopental Sodium
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Thiopental.
Ticlopidine
The metabolism of Etonogestrel can be decreased when combined with Ticlopidine.
Tipiracil
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Tipiracil.
Tipranavir
The serum concentration of Etonogestrel can be increased when it is combined with Tipranavir.
Tocilizumab
The serum concentration of Etonogestrel can be decreased when it is combined with Tocilizumab.
Tolazamide
The therapeutic efficacy of Tolazamide can be decreased when used in combination with Etonogestrel.
Tolbutamide
The therapeutic efficacy of Tolbutamide can be decreased when used in combination with Etonogestrel.
Topiramate
The serum concentration of Etonogestrel can be decreased when it is combined with Topiramate.
Tranexamic Acid
Tranexamic Acid may increase the thrombogenic activities of Etonogestrel.
Tretinoin
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Tretinoin.
Trisodium Citrate Anhydrous
The therapeutic efficacy of Sodium Citrate can be decreased when used in combination with Etonogestrel.
Troglitazone
The therapeutic efficacy of Troglitazone can be decreased when used in combination with Etonogestrel.
Troxerutin
The therapeutic efficacy of Troxerutin can be decreased when used in combination with Etonogestrel.
Ulipristal
The therapeutic efficacy of Etonogestrel can be decreased when used in combination with Ulipristal.
Vemurafenib
The serum concentration of Etonogestrel can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Etonogestrel can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Etonogestrel can be decreased when combined with Verapamil.
Vildagliptin
The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Etonogestrel.
Voriconazole
The serum concentration of Etonogestrel can be increased when it is combined with Voriconazole.
Warfarin
Etonogestrel may decrease the anticoagulant activities of Warfarin.
Ziprasidone
The metabolism of Etonogestrel can be decreased when combined with Ziprasidone.
